Background Dyslipidemia is one of the major modifiable risk factors for cardiovascular
diseases (CVD) in a type-2 diabetic (T2DM) patient. Dyslipidemia in T2DM patients is …

Purpose Dyslipidemia is a major risk factor for cardiovascular disease (CVD) in diabetic
patients and early detection and treatment can reduce its morbidity and mortality. There is …

Introduction Dyslipidemia is a key clinical abnormality among diabetes mellitus (DM)
patients, which heightens their risk of cardiovascular events. Data on the serum lipid profile …

Abstract Background and Objective: Lipid abnormalities are commonly found in persons with
diabetes mellitus but there is paucity of recent literature relating to local incidence. This …

Background: The problem of dyslipidemia is high in patients with diabetes mellitus. There is
ample evidence that abnormalities in lipid metabolism are important risk factors for …

Introduction: dyslipidemia confers excess atherosclerotic cardiovascular risk in type 2
diabetes mellitus (DM) patients, and this requires prompt identification and management to …

The association between dyslipidemia and diabetes mellitus is well established. Although
various lipoprotein abnormalities have been described in patients with diabetes mellitus …

Background Diabetes mellitus (DM) is a major health problem in Sudan and is a leading
cause of morbidity and mortality. Dyslipidemia is a major complication of diabetes and an …

Background: Diabetes mellitus is a major healthcare problem globally, and by 2030 there
will be approximately 360 million patients world–over. Diabetes mellitus is associated with …

Background Diabetes mellitus is a group of metabolic disorders that are caused by
deficiency in insulin secretion or the decreased ability of insulin to act effectively on target …